Results 121 to 130 of about 13,550 (188)

Novel KPC-2 variants and epidemic ST463 clones underlie ceftazidime/avibactam resistance in carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

Microbiol Spectr
Hu Y, Sun Q, Shen W, Du J, Kaiqi Z, Zhang R.   +5 more
europepmc   +1 more source

Ceftazidime-avibactam resistance in Klebsiella pneumoniae sequence type 37: a decade of persistence and concealed evolution. [PDF]

Microb Genom, 2023
Arcari G, Polani R, Bruno F, Capitani V, Sacco F, Menichincheri G, Raponi G, Carattoli A.   +7 more
europepmc   +1 more source

OmpK35/36 absence does not confer carbapenem-resistance alone nor ceftazidime-avibactam resistance with one <i>bla</i> _KPC-2. [PDF]

Front Cell Infect Microbiol
Wu S, Yang Y, Xiang W, Zhang J, Luo X, Xu M, Hu D, Zhang H.   +7 more
europepmc   +1 more source

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam

, 2019
Objectives: We characterized the first ceftazidime-avibactam-resistant KPC-producing-Klebsiella pneumoniae clinical isolate detected in Greece, before the introduction of ceftazidime-avibactam in clinical practice. Methods: K.
Giamarellou, H., Kontopoulou, K., Antoniadou, A., Souli, M., Galani, I., Karaiskos, I.   +5 more
core  

Ceftazidime-Avibactam Resistance in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bloodstream Infections: Risk Factors and Clinical Outcomes. [PDF]

Antibiotics (Basel)
Yanık A, Karaşahin Ö.
europepmc   +1 more source

Rapid replacement of blaKPC variant in ST11 carbapenem-resistant and hypervirulent Klebsiella pneumoniae contributed to ceftazidime/avibactam resistance during severe in vivo infection. [PDF]

J Antimicrob Chemother
Yang P, Liu C, Zheng J, Yi J, Wu Z, Tian Y, Du P, Lu M, Shen N.   +8 more
europepmc   +1 more source

Emergence of Ceftazidime-Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11 Klebsiella pneumoniae During Antibiotics Treatment. [PDF]

Infect Drug Resist, 2022
Xu M, Qian C, Jia H, Feng L, Shi S, Zhang Y, Wang L, Cao J, Zhou T, Zhou C.   +9 more
europepmc   +1 more source

Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis. [PDF]

Antimicrob Resist Infect Control
Wang Y, Sholeh M, Yang L, Shakourzadeh MZ, Beig M, Azizian K.   +5 more
europepmc   +1 more source

Diversity of Ceftazidime-Avibactam Resistance Mechanism in KPC2-Producing Klebsiella pneumoniae Under Antibiotic Selection Pressure. [PDF]

Infect Drug Resist, 2022
Jiang M, Sun B, Huang Y, Liu C, Wang Y, Ren Y, Zhang Y, Wang Y, Mu D.   +8 more
europepmc   +1 more source

High ceftazidime-avibactam resistance rate in carbapenem-resistant gram-negative organisms in Pakistan's pediatric population. [PDF]

Pak J Med Sci
Mehdi N, Majeed N, Ali F, Aroob I.
europepmc   +1 more source